Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN120577 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD3 (CD3) antibody (APC)
- Antibody type
- Monoclonal
- Description
- Size exclusion chromatography
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- MEM-57
- Vial size
- 100 tests
- Storage
- Store the antibody undiluted at 4-8°. DO NOT FREEZE! This product is photosensitive and should be protected from light. Should it contain a precipitate we recommend microcentrifugation before use.Shelf Life: one year from despatch.
Submitted references Therapeutic in vivo use of the A1-CD3 monoclonal antibody.
Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74).
[Indications for and results of tricuspid replacement by aortic valve homograft (author's transl)].
Hilgert I, Franĕk F, Stefanová I, Kaslík J, Jirka J, Kristofová H, Rossmann P, Soucek J, Horejsi V
Transplantation 1993 Feb;55(2):435-8
Transplantation 1993 Feb;55(2):435-8
Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74).
Horejsí V, Angelisová P, Bazil V, Kristofová H, Stoyanov S, Stefanová I, Hausner P, Vosecký M, Hilgert I
Folia biologica 1988;34(1):23-34
Folia biologica 1988;34(1):23-34
[Indications for and results of tricuspid replacement by aortic valve homograft (author's transl)].
Mikaeloff P, Fleurette J, Transy MJ, Brun Y, Sale JM, Cartalat A
Annales de chirurgie thoracique et cardio-vasculaire 1975 Apr;14(2):105-12
Annales de chirurgie thoracique et cardio-vasculaire 1975 Apr;14(2):105-12
No comments: Submit comment
No validations: Submit validation data